Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc. (NASDAQ:SGRY), recently sold 167 shares of the company's common stock. The shares were sold at an average price of $25.68 ...

Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following ...

Surgery Partners, Inc. (NASDAQ: SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers ...